Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
64 hedge funds and large institutions have $306M invested in Amryt Pharma plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 10 closing their positions.
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
4% less funds holding
Funds holding: 67 → 64 (-3)
12% less capital invested
Capital invested by funds: $348M → $306M (-$42.1M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$15.6M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.83M |
| 3 |
HCM
Highbridge Capital Management
New York
|
+$2.13M |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$1.77M |
| 5 |
AC
Armistice Capital
New York
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$9.93M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$3.86M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$1.2M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$510K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$311K |
AMYT Hedge Fund Activity: Q2 2022 in Review
64 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q2 2022, worth a combined $306M — down 12% from $348M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AMYT and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 17 added.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $15.6M. The largest seller was Man Group, exiting entirely with an estimated $9.93M sold.
- 64 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q2 2022, down from 67 in Q1 2022.
- Funds reported $306M of Amryt Pharma plc American Depositary Shares stock for Q2 2022, down 12% quarter-over-quarter.
- 7 funds opened new Amryt Pharma plc American Depositary Shares positions in Q2 2022 and 10 closed out, a net change of -3 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q2 2022 was UBS O'Connor, an estimated $15.6M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q2 2022 was Man Group, an estimated $9.93M sold.
Based on aggregated 13F filings for Q2 2022.